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SUMMARY 
 
 
Microsatellites, or structures of tandemly arranged 
repeats, are polymorphic loci in the genome which 
are inherited in a Mendelian pattern. At each locus 
both the maternal and the paternal counterpart 
bears an allele with a certain number of repeats. 
Multiplex analysis of several microsatellite loci 
creates an individual-specific DNA profile. 
Therefore, they are widely used for identification 
purposes, establishment of family relationships, 
genetic mapping and population studies. However, 
due to the repetitious structure, microsatellite DNA 
array is prone to mutations during the replication. 
This may cause problems in particular 
applications, e.g. in paternity analyses or disease 
linkage mapping, where a mutation may lead to 
false exclusion. Knowing the mutation frequency 
at a particular microsatellite locus may be essential 
in assessing the statistical interpretation of the 
DNA profile, e.g. in parentage testing. Mutation 
rates have been estimated by family studies, 
population-based algorithms or pedigree analysis. 
The rates have been found to be different between 
various loci and among alleles of a particular 
locus, depending on the repeat structure of the 
microsatellite locus.  
The aim of this study was to evaluate the 
stability of a set of microsatellite markers in 
gastrointestinal cancers from the perspectives of 
forensic DNA profiling and paternity testing, 
genetic integrity of cancer tissues, and population 
genetics. In tumour tissues which are known to 
harbour genetic instability two types of alterations 
may be observed. Firstly, the microsatellite 
instability (MSI) type with emergence of new 
alleles, and secondly loss of heterozygosity (LOH) 
type with loss of one allele of a heterozygote. 
High-level microsatellite instability (MSI-H) has 
been described as a distinct own entity, the mutator 
phenotype, in carcinogenesis. In this study a total 
of 66 gastrointestinal tumours (27 colorectal and 
39 gastric) were analysed in parallel with their 
histologically normal adjacent tissues. The DNA 
profiles of tumour and matching normal tissue 
were obtained using fifteen autosomal 
polymorphic tetranucleotide markers and the 
gender marker amelogenin. In addition, four X-
chromosomal tri- and tetranucleotide markers were 
studied to determine their allelic distribution in the 
Finnish population and in the gastrointestinal 
tumours.  
From the forensic and paternity testing perspective, 
the aim of the present work was to evaluate the 
appropriateness of tumour tissue as the source of a 
DNA profile of an individual. The interest was 
focused on the stability of the DNA in 
gastrointestinal tumour tissues, and on the 
occurrence of possible errors in DNA profiling 
when using such tissue material.  Gastric and 
colorectal cancers were chosen for the study 
because of their high incidence in the population 
and because of their inherent genetic instability. 
The reliability of the analysis is critical in cases 
where DNA profiling and subsequent identification 
or paternity testing should be performed from a 
tumour tissue sample. Only 27 (41%) of the 66 
tumour samples tested showed no alterations in 
their DNA profiles. The rest (59%) of the tumours 
had at least one alteration, either MSI or LOH. 
Male samples with frequent LOH also frequently 
showed loss of the Y-chromosomal gender marker 
amelogenin. The results show that when testing 
identity from tumour samples a heterozygote 
individual may be interpreted as a homozygote, a 
homozygote as a heterozygote, and a male as a 
female. An MSI-H sample without the 
corresponding control tissue could easily be 
detected, with at least one locus manifesting extra 
alleles, but the detection of LOH without the 
corresponding tissue was not straightforward. Thus 
careful interpretation of the data, and possibly the 
use of stable surrogate markers, is warranted when 
using tumour tissues as the source of DNA for 
forensic identification, especially in paternity 
analysis. 
The applicability of the human identification-
targeted markers in revealing MSI and LOH in 
colorectal and gastric cancers was also tested, with 
a special emphasis on gastric cancer. In 
comparison with previous studies using 
dinucleotide markers located on chromosomal 
regions known to be deleted in gastric cancer, this 
study assessed if the forensically widely used 
tetranucleotide markers would similarly detect 
aberrations of the cancer genome. The results 
indicate that MSI-H was efficiently detected by the 
markers, and LOH and low-level MSI (MSI-L) 
were found in equal amounts as in previous 
studies. Importance of detection of MSI-L has been 
debated, since no markers specific for it has been 
found. MSI-L has recently been suggested to 
represent a real phenomenon in e.g. colorectal and 
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endometrial cancer, however, these studies did not 
include gastric cancer. In the present work, we 
stratified gastric cancers according to MSI and 
LOH and found cancers with genetic instability to 
associate with the intestinal type of gastric cancer. 
In contrast, genetic stability, as revealed by these 
markers, was more prevalent in diffuse type 
cancer. MSI-L was suggested as a true phenotype 
also in gastric cancer, and in a novel finding, it was 
to shown to coexist in tumours with LOH-H. 
The third point of interest, relating to 
population genetics, was to evaluate the possibility 
that gastrointestinal tumours reflect the mutational 
properties of microsatellite loci in germ-line. 
According to our results, as assessed with X-
chromosomal markers with homogeneous repeats, 
the likelihood of a marker to allelic alterations in 
MSI-H tumours correlated with its allelic diversity 
in the population. It was proposed that a set of 
MSI-H tumours might serve as a test model to pre-
evaluate the mutational properties of a particular 
marker in a population. However, as tumours are 
subject to different selectional and tissue-specific 
effects than the germ-line cells and human 
populations, more studies are needed for 
straightforward comparisons. 
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REVIEW OF THE LITERATURE 
 
 
 
1. ORGANISATION OF THE HUMAN GENOME  
 
 
The diploid human genome consists of 6400 
gigabase pairs of DNA, of which half is inherited 
from the mother and half from the father. The 23 
chromosome pairs have therefore a maternal and a 
paternal counterpart. In addition to this, a small 
fraction of DNA, 16.5 kilobase pairs, 
corresponding to approximately 0.0003% of the 
total genome, is maternally inherited in 
mitochondria. The first human genome sequences 
were reported in 2001 (Venter et al. 2001, The 
International Human Genome Sequencing 
Consortium 2001) and a more accurate whole-
genome assembly was reported three years later 
(Istrail et al. 2004). According to the whole-
genome sequence, only 1% of the DNA was found 
to consist of exons, 24% of introns, while the 
function of the remaining 75% is not precisely 
known to date (Venter et al. 2001).  
The human genome can be divided into single-
copy and repetitive DNA, and regions coding for 
genes are usually placed in the former category. 
The latter category comprises roughly 45% of the 
genome. The repetitive elements may be 
categorised into short interspersed elements 
(SINE) and long interspersed elements (LINE), 
and tandemly arranged repeats e.g. mini- and 
microsatellites (Li et al. 2001). The human 
genome has been reported to contain more than 
4.3 million repetitive elements, with Alu repeats of 
the SINE category and L1 repeats of the LINE 
category being the most frequent (Li et al. 2001). 
Figure 1 illustrates an overview of the 
organisation of the human genome. 
 
THE HUMAN GENOME 
Gene/gene related 
sequences     ~30%
Extragenic DNA  ~70%
Interspersed 
repeats
Tandemly
repeated
Minisatellite
Microsatellite
Coding 
Regions
~3%
Introns, promoters, 
pseudogenes, gene 
fragments ~27%
Repetitive  ~15% Unique  ~55%
LINE
SINE
100%
Satellite
 
Figure 1. Organisation of the human genome and division into categories of single-copy and 
repetitive elements. Figure modified from Bennett (2000). 
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2. MICROSATELLITES 
 
 
Microsatellites, or short tandem repeats (STRs), 
are regions of repetitive DNA in the genome 
(Tautz 1989, Weber and May 1989). The length of 
the repeating unit is 1-6 basepairs (bp) and the size 
of the repeat ranges around a mean of 100 bp 
(reviewed by Koreth et al. 1996 and Ellegren 
2004). Microsatellites show a high degree of 
polymorphism at the population level and are 
found in all eukaryotic genomes like yeast, fruit 
flies, mice, primates or plants, e.g. Cannabis sativa 
(Tautz 1989, Tòth et al. 2000, Gilmore et al. 
2003). The polymorphism is due to a high number 
of alleles per locus, each bearing a different 
number of repeats, which are inherited in a 
Mendelian fashion. Thus every individual carries a 
unique set of microsatellites in his or her genome 
and passes half of them to their offspring. 
Therefore, microsatellite analysis is widely used in 
mapping of genetic disease and in population 
genetic and evolutionary studies, and in forensic 
applications (Koreth et al. 1996). The repetitive 
DNA regions are prone to mutations and thus they 
can be used in determining the relationships among 
very closely related species or individuals (Koreth 
et al. 1996, Tòth et al. 2000, Forster et al. 2000). 
The human genome is estimated to have 40 000 
microsatellite loci, comprising about 3% of the 
total DNA (Subramanian et al. 2003). Although 
the overall densities of microsatellite repeats are 
relatively uniform across human chromosomes, the 
densities vary according to location (Subramanian 
et al. 2003). Microsa-tellites can be divided into 
mono-, di-, tri-, tetra-, penta- and hexanucleotides 
depending on the length of the repeat unit. 
Mononcleotide repeats are the most copious (Tòth 
et al. 2000, Subramanian et al. 2003). The 
abundance of microsatellites decreases with the 
length of the repeat unit, i.e. penta- and 
hexanucleotide repeats are relatively rare. The 
repeat structure also correlates with the abundance 
of the repeat, e.g. (AC)n and (AT)n occur more 
frequently than (AG)n and (GC)n (Rubinsztein et 
al. 1995, Subramanian et al. 2003). Microsatellites 
are distributed throughout the genome in coding 
and noncoding regions but their precise role, if 
any, is not well understood (Tòth et al. 2000, 
Subramanian et al. 2003).  
Trinucleotide repeats have been found in coding 
regions with a twofold density compared to other 
repeats; they can show length variation without 
interrupting the reading frame (Submaranian et al. 
2003). The length polymorphism at these repeats 
may cause susceptibility to certain clinical 
conditions, e.g. polymorphism at the androgen 
receptor (ARA) CAG region has been suggested to 
correlate with male infertility (Wallerand et al. 
2001). However, for unknown reasons, some of 
these coding triplet repeats undergo rapid 
expansion causing severe diseases such as 
Huntington’s disease, Fragile X syndrome, 
Kennedy disease or Myotonic dystrophy 
(Biancalana et al. 1992, Fu et al. 1992, Snell et al. 
1993,  Verheij et al. 1993, Cummings and Zoghbi 
2000). A recent whole-genome in silico survey 
found 62 such triplet-repeat genes, of which 14 are 
known to have disease-causing expansions (Collins 
et al. 2003). 
 
 
Table 1. Examples and characteristics of simple and complex repeats.  
Locus name Structure Repeata Allelesb (n) Repeat Rangec Reference 
HPRTB simple (tcta)x 8 9-16 Edelmann et al. 2001 
D7S808 simple (cttt)x 12 7-11 Akiyama et al. 2002 
D6S683 complex (tcta)x(ta)1(tcta)0-2(ta)0-1(tcta)x 12 13.2-22 Barrall et al. 2000 
D22S6823 complex (tatatc)x(tatc)x(atc)0-1(tatc)x 20 12-21 Barrall et al. 2000 
a The repeating unit is indicated in parentheses, where x is the number of repeats. 
b  Number of alleles found in a population. 
c The range of repeat number. 
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The structures of microsatellites can be divided 
into simple and complex repeats. The simple 
repeats consist of an uninterrupted run of units 
sharing the same sequence (Urquhart et al. 1994, 
Kayser et al. 2004). For nomenclature purposes the 
observed number of repeats forms the basis of 
allele calling (Bär et al. 1997, Kayser et al. 2004). 
Simple repeat loci may also have variant alleles 
with an insertion or deletion of one base in one of 
the repeat units. Their nomenclature is based on 
the number of perfect repeats followed by the 
number of bases in the imperfect portion. For 
instance, the sequence for the TH01 allele 9.3 is 
(AATG)6-ATG-(AATG)3, whereas for allele 9 it is 
(AATG)9. Complex microsatellites consist of 
interrupted repeats or repeats different in sequence 
or size. Uncertainties in recognising the repeat and 
its direction may lead to confusion (Szibor et al. 
2003a, Kayser et al. 2004). The nomenclature can 
be based either on the overall number of repeats or 
by the length of the amplicon in base pairs (Bär et 
al. 1997, Kayser et al. 2004). Examples of simple 
and complex microsatellites are shown in Table 1. 
 
 
 
3. MICROSATELLITE ANALYSIS IN FORENSIC MEDICINE 
 
 
 
3.1. Human identification 
 
 
The invention of the polymerase chain reaction, 
PCR (Saiki et al. 1985, Mullis and Faloona 1987), 
represented a break-through for the analysis of the 
human genome in biomedical sciences. For 
resolving forensic questions, individual variation in 
a set of polymorphic loci could be revealed e.g. by 
simultaneously amplifying several microsatellite 
regions. By using modern techniques the 
individual-specific DNA profile can be obtained 
from a small number of cells and analysed through 
high-throughput electrophoresis (reviewed by 
Butler et al. 2004). Because the DNA sequence in 
general is uniform in all tissues of an individual 
almost any tissue can serve as a DNA source. By 
choosing a set of highly polymorphic 
microsatellites for the amplification procedure, an 
efficient and reliable way to discriminate between 
individuals is achieved. Tri- and tetranucleotide 
microsatellites are preferred in human 
identification, because of the accurate allele calling 
due to lower occurrence of PCR-based artefacts 
(Urquhart et al. 1994). The multiplex amplified 
PCR products are separated according to their 
sizes, and the differently migrating fragments are 
visualised by DNA staining or detection of 
fluorescent signals (“peaks”) generated by labelled 
PCR primers (Butler et al. 2004). Allelic ladders 
help the allele-calling in samples of unknown 
identity. Based on the frequencies of different 
genotypes in a given population, a probability for 
the incidence of a particular genotype may be 
determined. 
Gender determination is usually included the 
amplification procedures by analysing of an X-Y 
homologous gene amelogenin (Sullivan et al. 
1993). Designing the amelogenin primers so that a 
region of different length in both chromosomes is 
amplified, unequivocal gender determination 
(female XX or male XY) is achieved. However, 
certain Y-chromosomal haplotypes have been 
shown to lack the amelogenin gene, hence the 
individual is typed as XX instead of XY (Santos et 
al. 1998, Roffey et al. 2000, Steinlechner et al. 
2002, Tharangaj et al. 2002, Chang et al. 2003, 
Michael and Brauner 2004). Also the X-
chromosomal amelogenin signal has been found to 
be absent as a result of a C-to-G transversion in the 
region where the commonly used genotyping 
primers bind (Shadrah et al. 2004). 
Different commercial genotyping kits for 
detecting different loci are currently available. In 
order to facilitate comparison of DNA profiles, a 
set of core markers has been agreed upon in the 
forensic community (Butler et al. 2004). These 
markers are always typed in casework samples, for 
population genetic studies, and for criminal 
offender DNA-register purposes. For example, the 
13 core markers selected by the Federal Bureau of 
Investigation (FBI) include CSF1PO, FGA, TH01, 
TPOX, vWA, D3S1358, D5S818, D7S820, 
D8S1179, D13S317, D16S539, D18S51, and 
D21S11 (Butler et al. 2004). Figure 2 illustrates a 
DNA profile obtained by AmpFlSTR® SGM™, 
which includes ten of the markers used by the FBI. 
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DNA profiles can also be reliably achieved from 
minute amounts of DNA or severely degraded 
human-derived material. A hair shaft or a cigarette 
butt from a crime scene can serve as a source of 
DNA (Hochmeister et al. 1991, 1995). 
Decomposed bodies and bone samples can also be 
used as a source of DNA because bone tissue DNA 
is well protected against degradational artefacts 
(Hoff-Olsen et al. 2001). For instance, the 
identification of Joseph Mengele (Jeffreys et al. 
1992) and the Romanov family (Gill et al. 1994) 
has been based on microsatellite analysis of 
skeletal remains. Choosing primers which result in 
shorter amplicon lengths may enrich the chance to 
obtain results from degraded DNA (Hoff-Olsen et 
al. 2001). 
In some cases, cancerous tissue has also served as 
a DNA source in identification studies. For 
instance, when tissue blocks are mislabelled in a 
pathology laboratory and their sources has to be 
identified, DNA profiles between the tissue 
specimen and the patient should match 
(Banaschack et al. 2000, Iwamoto et al. 2003). In 
some cases where reference DNA is required for 
the identification of a deceased person or a 
disputed paternity has to be confirmed, the only 
reliable source may be a paraffin block of a 
malignant tissue from a histology archive. In such 
cases, the DNA profiles must be interpreted with 
caution (Rubocki et al. 2000, Pai et al. 2002, 
Poetsch et al. 2004, Schwark et al. 2004). 
 
vWA 
 
Figure 2. Electropherograms 
obtained with AmpFlSTR SGM Plus 
set of markers. Three different dye 
channels (blue in the upper, green in 
the middle and black in the lower 
graph) and the genotype of 
individual loci are indicated. 
 
 
 
 
3.2. Paternity analysis 
 
 
Paternity and kinship analysis can be effectiv
performed by analysis of microsatellites (Thom
et al. 1999, 2001). The parents pass one of t
alleles from each of the loci to their descenda
In cases with normal chromosomal transmiss
one allele of a particular autosomal microsate
locus is inherited from the father and the o
from the mother. By comparing the DNA prof
of the child, mother and putative father, statist
interpretation in a form of the paternity index 
be calculated in cases where an parenthood is 
excluded (Thomson et al. 1999). In the fut
however, it may be foreseeable that a high num
 3
D3S1358
15-16
16-17
D16S539
11-11
D2S1338
21-25
AMEL
X-X
D8S1179
13-16
D21S11
29-30.3
D18S51
13-13
D19S433
14-16.2
TH01
7-10 FGA
21-23
ely 
son 
heir 
nts. 
ion, 
llite 
ther 
iles 
ical 
can 
not 
ure, 
ber 
of single nucleotide polymorphisms (SNPs) will be 
analysed in addition to or instead of microsatellite 
loci. The advantage of SNPs is the low mutation 
rate (10-8) in comparison to microsatellites (in the 
range of 10-3), although the number of SNPs 
needed for achieving high paternity indexes is 
much higher that that of microsatellites (Gill 2001, 
Amorim and Pereira 2004). However, since the 
detection of multiple SNPs per sample needs high 
throughput detection and re-generation of criminal 
offender registers, the present system is to date the 
most convenient method. 
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When the descendant in question is a male the Y-
chromosomal microsatellites may be used in 
paternity analyses, especially in deficiency cases 
where the alleged father is deceased (Kayser et al. 
1997, Ruitberg et al. 2000). The non-
pseudoautosomal region of the Y chromosome 
does not recombine during meiosis and it is 
inherited as a haplotype. Therefore, all the loci 
found in the father and the descendant are of one 
genotype unless mutations occur, and the Y-
chromosomal haplotype may be traced as a 
paternal lineage to distant male relatives or 
pedigree ancestors (Carvalho-Silva et al. 1999, 
Forster et al. 2000). For instance, Y-chromosomal 
analysis has revealed new insight to the disputed 
paternity of President Thomas Jefferson of Sally 
Heming’s descendant(s) (Forster et al. 1998). 
In some particular cases when the child with 
disputed parentage is a female X-chromosomal 
microsatellite markers can be used (Edelmann et 
al. 2001, Zarrabeitia et al. 2002a, 2002b, Wiegand 
et al. 2003, Szibor et al. 2003a, 2003b, Shin et al. 
2004). The putative father carries a single X-
chromosome, and the haplotype is passed on to the 
daughter. Therefore, the analysis of X-
chromosomal microsatellites may be, e.g. in 
deficiency cases where one of the parents is 
missing, more informative than conventional 
autosomal microsatellite analysis (Szibor et al. 
2003b). Figure 3 and Table 2 illustrates X-
chromosomal analysis in a family case. 
However, as with all genetic markers, solving 
disputed paternity or kinship may be problematic 
when mutations are found in the descendant 
(Thomson et al. 1999, Kayser and Sajantila 2001). 
Therefore, the estimation of microsatellite 
mutation rates is of great importance in forensic 
DNA studies. Markers with high mutability may 
result in erroneous identity when analysing kinship 
(Brinkmann et al. 2001), e.g. in investigations by 
reverse paternity for victims of war (Gornik et al. 
2002). In addition, understanding the mechanisms 
and factors underlying the mutations may reveal 
new insights to the evolution of the microsatellites. 
 
 
 
 
Mother
XX
Daughter 
XX
Father 
XY
Son 
XY
 
 
Figure 3. The pattern of X-chromosomal inheritance. 
 
 
 
 
 
 
 
 
Table 2. The X-chromosomal genotype in a 
family case. The son has maternal alleles. The 
daughter has a combination of maternal and 
paternal alleles. 
 DXS7423 DXS101 DXS8377 ARA 
Mother 13-15 24-24 48-49 23-25 
Father 13 26 49 30 
Son 13 24 49 23 
Daughter 13-15 24-26 48-49 23-30 
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4. MICROSATELLITE MUTATIONS IN THE GERM-LINE 
 
 
 
4.1. Mutational mechanism and dynamics 
 
 
Molecular mechanisms underlying the mutations 
of microsatellite loci are thought to result from the 
interplay between replication errors and their post-
replication repair. The error-producing mechanism 
has been suggested to be slippage of the DNA 
polymerase enzyme (reviewed by Ellegren 2004). 
Replication slippage or slipped-strand mispairing, 
as illustrated in Figure 4, refers to the 
misalignment of the two DNA strands after strand 
dissociation (“strand breathing”) prior to 
polymerisation (Ellegren 2004). The observed 
slippage rates vary between organisms and it may 
explain the observed variation in microsatellite 
length distribution (Krugylak et al. 1998, Ellegren 
2004). The “stepwise mutation model”, where 
alleles increase or decrease by one unit, was 
concluded to originate from replication slippage, 
observed as mutations occurring in single steps 
(Levinson and Gutman 1987). The best fit with the 
allelic distributions seen in populations was 
obtained with this model (Weber and Wong 1993, 
Valdes et al. 1993, Chakraborty et al. 1997, 
Klintschar and Wiegand 2003). Data obtained from 
family studies corroborate the single-step model, 
although longer changes of two or three repeat 
units have also been noticed (Sajantila et al. 1998, 
Kayser et al. 2000, Brinkmann et al. 1998, 
Leopoldino and Pena 2003). However, another 
study found dinucleotide markers to change mostly 
by larger steps (Huang et al. 2002). This may 
indicate a different mechanism for dinucleotides 
compared with longer repeat microsatellite motifs. 
The evolution of a microsatellite sequence can 
be considered as a balance between slippage events 
and point mutations (Krugylak et al. 1998). A 
microsatellite may contain more than one repetitive 
tract, but only one repeat region is suggested to be 
polymorphic and thus harbour all the detectable 
mutations (Leopoldino and Pena 2003). Depending 
on the primer locations, however, the amplification 
product may contain more than one microsatellite 
tract and thus more polymorphic regions may be 
observed (Kayser et al. 2004). Various factors 
have been found to affect mutation rates 
(Schlötterer 2000, Ellegren 2004) 
. 
 
 
 
 
A
B C
 
 
 
Figure 4. The strand slippage model for microsatellite mutations. The DNA strands dissociate 
from each other (A) and re-anneal with a mismatch of one repeat unit. A mismatch in the template 
strand results in contraction (B), while a mismatch in the nascent stand results in expansion (C). 
Figure modified from Ellegren (2004). 
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For instance, the average repeat number at a locus 
has been shown to be proportional to its 
polymorphism (Chakraborty et al. 1997, Ellegren 
2000). Accordingly, the geometric mean of the 
longest run of perfect repeats has been found to 
correlate with germ-line mutations (Brinkmann et 
al. 1998, Leopoldino and Pena 2003). Smaller 
alleles seem to have a tendency to gain repeat 
units, whereas long alleles tend to lose repeats (Xu 
et al. 2000, Huang et al. 2003, Dupuy et al. 2004). 
However, the existence and nature of upper (and 
lower) boundaries on allele size are still unknown 
(Ellegren 2000, Xu et al. 2000). Sequence 
interruptions by imperfect repeats lead to 
stabilisation of the microsatellite (Brinkmann et al. 
1998, Bacon et al. 2000, Sturzeneker et al. 2000). 
In addition to the differences in mutation rates in 
different microsatellite loci, the mutation rates 
have also been observed to vary among the alleles 
of the same locus (Jin et al. 1996, Carvalho-Silva 
et al. 1999, Ellegren 2000). 
A male bias in germ-line mutations has been 
noticed (Ellegren 2004), but the tendency for 
maternal and paternal mutations may also be locus-
specific (Henke and Henke 1999). The sex-specific 
mutation rates are suggested to originate from a 
larger number of mitotic cell divisions in 
spermatogenesis than in oogenesis, with an 
assumption that most mutations are replication-
dependent (Ellegren 2000). Therefore, the 
mutations should also correlate with paternal age, 
but as yet no significant difference has been 
observed (Sajantila et al. 1998, Kayser et al. 2000, 
Kayser  and Sajantila 2001, Leopoldino and Pena 
2003, Dupuy et al. 2004).  
 
 
 
4.2. Inferring mutation rates 
 
 
The mutations of microsatellites manifest cell 
division. Thus, having an estimation of the 
mutation rates at certain loci is critical e.g. when 
dating the last recent common ancestor from 
phylogenetic data (Morral et al. 1994). The most 
straightforward way to obtain mutation frequencies 
is to analyse family data and directly observe 
inconsistencies in parent-descendant allelic 
transfers. However, a large number of samples are 
needed for reliable mutation rates (Sajantila et al. 
1998, Brinkmann et al. 1998, Xu et al. 2000, 
Leopoldino and Pena 2003, Dupuy et al. 2004). 
One study has been conducted on mutational 
frequencies observed directly from diluted pools of 
sperm DNA (Holtkemper et al. 2001). However, 
this study directly observed only the repeat gains 
from which the total mutation rate was 
extrapolated, giving a result of higher estimates 
than in studies with direct pedigrees. Table 3 
summarises the observations of six studies with 
parent-descendant allelic transfers. 
 
 
 
 
 
Table 3. Mutation rates and the proportion of single step events at autosomal and Y-
chromosomal loci observed in family studies. 
 
Locus Study Allele transfers 
(n) Type a (n) 
Averaged 
mutation rate 
Single step 
events 
Paternal 
originb
Sajantila et al. (1998) 29.640  AS 5 0.6 X 10-3 56% 100% 
Brinkmann et al. (1998) 10.844 AS 9 2.1 X 10-3 96% 85% 
Leopoldino et al. (2003) 24.224 AS 10 9.5 X 10-4 96% 82% 
Xu et al. (2000) 287.786 AS 122 1.8 X 10-3 85% 76% 
Kayser et al. (2000) 4.999 Y-STR 15 2.8 X 10-3 93%  
Dupuy et al. (2004) 15.894 Y-STR 9 2.3 X 10-3 96%  
a AS, autosomal, Y-STR, Y-chromosomal. 
b Percent of cases where the mutating allele could be deduced. 
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Mutation rates may also be inferred by deep 
rooting pedigrees e.g. in the non-recombining Y-
chromosomes or autosomal microsatellites with 
linkage to a haplotype (Forster et al. 2000, 
Carvalho-Silva et al. 1999, Heyer et al. 1997, Lin 
et al. 1996, Hästbacka et al. 1992, Morral et al. 
1994). These methods give only estimates of the 
actual mutational frequencies, because the 
ancestral haplotypes and thus paternity are not 
confirmed. In addition, as both additions and 
deletions of the repeat units are possible, the 
results are not reliable because an allele can mutate 
back to its original length (Carvalho-Silva et al. 
1999). The allelic distribution seen in a population 
can also help in inferring mutation rates, assuming 
that the demographic history of the population is 
known (Chakraborty et al. 1997, Di Rienzo et al. 
1998, Andrés et al. 2003). Because of obligatory 
uncertainties in the demographic history of 
populations and population effects unknown to 
date, the mutation rates obtained this way may not 
be fully reliable. However, loci with the highest 
levels of polymorphism at the population level 
have been suggested to have the highest rate of 
germ-line mutations (Ellegren 2004). 
 
 
 
 
5. MICROSATELLITE ANALYSIS IN CANCER RESEARCH 
 
 
In the progression of cancer the tumour 
accumulates genetic changes in genes that control 
cell birth and death, thus enabling growth and 
metastasis by the tumour cell population. These 
changes can affect the whole genome by 
alterations in chromosome number or 
chromosomal translocations or amplifications, or 
affect single genes by introducing point mutations, 
insertions or deletions. The selective conditions in 
the tumour environment give rise to clonal 
expansion, allowing the tumour cell with the 
mutated allele to outnumber its sister cells 
(reviewed by Lengauer et al. 1998 and Loeb et al. 
2003). However, the mechanisms which enable 
these mutations to arise are still unknown. Normal 
mutation rates have been suggested to be 
insufficient to produce the observed mutations, 
despite the high number of cell divisions during 
the final clonal expansion of the tumour. Thus it 
has been proposed that an underlying genetic 
instability, i.e. mutator phenotype, is required to 
generate the numerous mutations observed in 
particular tumours (Loeb et al. 2003). In order to 
produce the mutator phenotype a primary loss of 
function in a key process is needed which enables 
the increase in mutation rates. These key 
processes may be controlled by factors which are 
involved in controlling genetic integrity, i.e. 
enzymes involved in replication (e.g. helicases), 
error correction (e.g. mismatch repair) or mitosis 
(e.g. chromosome segregation) (Lengauer et al. 
1998, Jallepalli and Lengauer 2001, Levitt and 
Hickson 2002 and Loeb et al. 2003). Furthermore, 
some of these genes have also been found to 
predispose to recessive genetic syndromes with 
increased risks of cancer (reviewed by Hickson 
2003 and D’Andrea and Grompe 2003). 
Microsatellites have been frequently used in 
cancer research, because they are distributed 
throughout the genome, act as mutational hotspots 
due to their repetitious nature, and allow 
determination of genomic changes due to high 
heterozygosity (reviewed by Koreth et al 1996 and 
Bennett 2000). Thus, microsatellite analysis may 
be used as an indication of genomic integrity. The 
detection of single point mutations or small 
insertions or deletions in non-repetitive areas is 
laborious because the regions manifesting 
mutations cannot be predicted. Comparing the 
DNA profiles obtained by microsatellites of a 
tumour and its neighbouring non-cancerous tissue 
(or blood lymphocytes) may reveal two different 
types of alterations. The emergence of alleles not 
present in healthy tissue is termed microsatellite 
instability (MSI) (reviewed by Loeb 1994, 
Lengauer et al. 1998 and de la Chapelle 2003), 
whereas loss of one of the heterozygote alleles is 
termed loss of heterozygosity (LOH) (Lasko et al. 
1991, Tomlinson et al. 2002). Figure 5 illustrates 
MSI and LOH. 
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Figure 5. Examples of MSI (panel A) and LOH (panel B) at the vWA microsatellite locus. 
T denotes tumour and N normal tissue. 
 
 
 
5.1. Microsatellite instability 
 
 
The MSI phenomenon, occurring in a subset of 
colorectal cancers, was found simultaneously by 
three research groups (Aaltonen et al. 1993, Ionov 
et al. 1993, Thibodeau et al. 1993). Most of the 
tumours found in the patients with the hereditary 
non-polyposis colon carcinoma (HNPCC) 
syndrome, a dominantly inherited disorder, were 
found to manifest MSI (Aaltonen et al. 1993). The 
linkage of MSI with a hereditary condition lead to 
the characterisation of two predisposing 
chromosomal regions (Peltomäki et al. 1993, 
Lindblom et al. 1993). Soon thereafter, similarities 
between the syndrome phenotype and mismatch 
repair (MMR) deficiency of E. coli was found, and 
the defective genes in HNPCC were found to be E. 
coli MMR-component homologues MLH1 and 
MSH2 (Fishel et al. 1993, Bronner et al. 1994). 
The key event leading to the MSI phenotype in 
HNPCC was found to be the loss of MMR function 
by somatic inactivation of the wild-type allele, thus 
resulting in the mutator phenotype (Loeb 1994). 
MSI was also found to occur in somatic tumours 
and in cancers other than colorectal ones (Rhyu et 
al. 1994, Boland et al. 1998), summarised by 
Lawes et al. (2003). In 90% of the sporadic 
gastrointestinal tumours the mutator phenotype has 
been shown to result from down-regulation of 
MLH1 by promoter hypermethylation (Thibodeau 
et al. 1998, Herman et al. 1998, Fleisher et al. 
1999, Yamamoto et al. 1999). The MMR system 
was originally characterised in E. coli, where it 
was found to recognise and correct mismatches in 
hemimethylated DNA (Lu et al. 1983). Bacterial 
strains with deficient MMR genes were also found 
to accumulate mutations in their genomes 
(reviewed by Schofield and Hsieh 2003). 
Individuals with homozygote MLH1 mutant alleles 
(MLH1-/- genotype) have recently been found, all 
of which share phenotypical features of 
neurofibromatosis 1 and hematological 
malignancies (Ricciardone et al. 1999, Wang et al. 
1999). Investigation of one MLH1-/- case revealed 
wide-spread MSI in the apparently healthy somatic 
tissues of this individual (Vilkki et al. 2001). 
MSI tumours accumulate point mutations and 
small insertions and deletions, but the “hot spots” 
are regions of repetition, e.g. microsatellite loci 
including also regions of mononucleotide repeats. 
Because the replication errors are less accurately 
corrected due to impaired function of the MMR 
genes, an insertion or deletion at a coding region 
may lead to a shift in the reading frame and thus to 
the loss of function of the protein product (Duval 
and Hamelin 2002). A two-base (AA) deletion in 
the TGFβ receptor II gene and subsequent 
truncation of the protein is illustrated in Figure 6. 
The TGFβ receptor II gene was the first target gene 
found, being mutated in 90% of MSI cancers 
(Parsons et al. 1995). Many other genes, such as 
BAX, hMSH6 and IGF2R, have been described as 
target genes in cancers with the mutator phenotype 
(Oliveira et al. 1998, Ottini et al. 1998, Vilkki et 
al. 2001, Mori et al. 2001, Duval et al. 2002). 
However, the critical targets for mutation in MSI-
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driven carcinogenesis are still poorly characterised, as reviewed by Duval and Hamelin (2002). The 
target mutations may also show tissue specificity, 
as reported for endometrial, gastric and colorectal 
cancers (Duval et al. (2002).  
Tumour tissues with somatic MSI can be 
subdivided into low- and high-frequency MSI 
phenotypes. For the distinction between these two 
types, the National Cancer Institute (NCI) has 
selected a panel of five mono- and dinucleotide 
markers. High frequency MSI tumours (MSI-H), 
with novel alleles in at least two of the five 
markers, display the mutator phenotype (Boland et 
al. 1998). The MSI-H genotype may also be 
assessed with any set of markers, where the cut-off 
limit for MSI-H can be set between 33-40% 
(Boland et al. 1998). Therefore, also tri- and 
tetranucleotide repeats may be used for 
determination of MSI phenotype (Samowitz et al. 
1995, Dietmaier et al. 1997, Boland et al. 1998). 
For instance, a complex Alu variable poly(A) 
marker MYCL1 with mono- and tetranucleotide 
repeats has been favoured in MSI detection 
(Young et al. 1995, Dietmaier et al. 1997, Jass et 
al. 2001). MSI-H tumours also show specific 
contractions at certain mononucleotide repeats. A 
quasi-monomorphic 26-adenine repeat (BAT-26) 
located in the fifth intron of MSH2 has been 
widely used in studies of microsatellite instability. 
This marker has been reported to reveal the MSI-H 
phenotype of sporadic colorectal and gastric 
cancers with 99.4%-100% accuracy (Hoang et al. 
1997, Halling et al. 1999) and it has been 
suggested to be sufficient for MSI-H detection 
even in tumours without the matching normal 
tissue. However, since polymorphism at the BAT-
26 locus has been detected in individuals of 
African origin (Pyatt et al. 1999), careful 
interpretation is needed if MSI-H detection is 
based solely on this marker. 
Low-frequency MSI (MSI-L) tumours exhibit 
sporadic new alleles. In MSI-L, less than one-third 
of the loci analysed, or one of the loci in the NCI 
panel, is affected (Boland et al. 1998). BAT-26 is 
never or rarely altered in MSI-L tumours. The 
mechanism for microsatellite alterations in MSI-L 
tumours is currently unknown, but they may 
originate from an increased rate of errors upon 
DNA replication (Jass et al. 2002) or from normal 
replication errors which become detectable by the 
clonal expansion of a tumour tissue (Laiho et al. 
2002, Halford et al. 2002). Differentiation of MSI-
L from microsatellite stable (MSS) tumours is 
uncertain and controversial (Jass et al. 2001), 
because when the number of markers is increased 
more MSS tumours will probably be re-categorised 
as MSI-L (Laiho et al. 2002, Halford et al. 2002). 
No specific markers for MSI-L or clear biological 
differences between MSI-L and MSS cancers have 
been found (reviewed by Tomlinson et al. 2002). 
Therefore the MSI-L tumours are usually included 
in the MSS group (Umar et al. 2004). However, 
the MSI-L phenotype has been recently shown to 
associate with ovarian, endometrial and colorectal 
cancers and it was therefore suggested to represent 
a real phenomenon (Halford et al. 2003). 
 
GAA AAA AAA AAG CCT GGT
----Glu-Lys-Lys-Lys-Pro-Gly----
GAA AAA AAA GCC TGG T
----Glu-Lys-Lys-Ala-Trp-(stop)
NON-REPAIRED
REPLICATION ERROR 
 
 
 
Figure 6. Microsatellite mutation at the (A)8-repeat of the TGFβ-receptor II gene in colon 
cancer. The two-base deletion in the coding region interrupts the reading frame, leading to a 
premature translational stop codon. Figure adopted from Lengauer et al. (1998).
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5.2. Loss of heterozygosity 
 
 
The concept of LOH is based on the hypothesis 
that two hits are needed for inactivation of tumour 
suppressor genes (Knudson 1971). According to 
the Knudson theory, both alleles of the tumour 
suppressor gene need to be inactivated for 
tumorigenesis, either by intragenic mutations, loss 
of the corresponding chromosomal region or 
methylation of the promoter (reviewed by Jones 
and Laird, 1999), of which only chromosomal 
losses may be detected by microsatellite analysis. 
Normally, the two alleles of a heterozygote should 
be detected at near-to-equal intensities depending 
on the detection methods. In tumours LOH is seen 
as a loss or reduced intensity of the other allele of a 
heterozygote genotype (reviewed by Lasko et al. 
1991, Knudson 2001 and Tomlinson et al. 2001, 
2002b). Usually heterozygote signal ratios falling 
below 0.5 in tumour tissues are interpreted as 
LOH. However, low DNA concentration and 
fragmented or chemically modified genomic 
material, e.g. formaldehyde-fixed paraffin-
embedded tissue, may result in artefactual LOH 
(Sieben et al. 2000). Apparent LOH does not 
necessarily mean chromosomal loss; the cells may 
still have two chromosomes (a duplication of one 
and a loss of the other) or have severe 
rearrangements (Thiagalingam et al. 2001). 
Therefore, LOH should not solely be considered as 
a deletion, as frequently reported, but alternatively 
as a gain of genetic material resulting from e.g. 
chromosomal duplication or sub-chromosomal 
amplification (reviewed by Tomlinson et al. 2001 
and Thiagalingam et al. 2002). However, it must 
also be kept in mind that an apparent LOH may 
also be a result of a point mutation in the region for 
amplification primer binding (Clayton et al. 2004). 
Therefore, the putative loss has to be confirmed by 
amplification with alternate primers. 
Usually LOH is thought to indicate 
chromosomal instability, which can be seen as 
chromosomal rearrangements and aneuplody at the 
karyotype level (Thiagalingam et al. 2001). The 
amount of LOH has been suggested to correlate 
with tumour progression and growth patterns (Choi 
et al. 1998). It has also been postulated that LOH 
and MSI-H occur as mutually exclusive (Lengauer 
et al. 1998), but this has recently been questioned 
(Goel et al. 2003, Tang et al. 2004, Hiyama et al. 
2004). However, distinguishing LOH from MSI in 
MSI-H tumours may be troublesome, since an 
apparent LOH may be a homozygous genotype 
generated by MSI or result from a mutation in the 
primer binding site. Assessing LOH in allelotyping 
analysis has been used in the search for tumour 
suppressor genes, because the loss of one 
functional gene by LOH and impaired function of 
the other by some other mechanism might give a 
growth advantage to the cell clone and enhance 
tumorigenesis (Vogelstein et al. 1989, Shen et al. 
2000). However, although LOH is frequent in 
tumours, very few studies have succeeded in 
identifying new tumour-suppressor genes as targets 
of LOH (Tomlinson et al. 2002). 
 
 
 
5.3. MSI and LOH in colorectal and gastric cancer 
 
Colorectal cancer (CRC) is the most common 
cancer in Western countries. Approximately 15% 
of sporadic CRC cases show MSI-H phenotype; 
this is mainly caused by epigenetic silencing of 
MLH1. In HNPCC, which occurs in 1-5% of all 
CRC cases, almost all individuals harbour a 
mutation in one of the three genes (MLH1, MSH2 
and MSH6) coding for MMR proteins (Fishel et al. 
1993, Bronner et al. 1994, de la Chapelle 2003). 
Almost all of the HNPCC tumours show MSI-H, 
hence detection of unstable microsatellite loci is 
one of the diagnostic methods used (Dietmaier et 
al. 1997, Boland et al. 1998). The MSI-H 
phenotype is known to associate with tumours 
arising in the right colon, with poor differentiation 
or mucinous cell type, lymphocyte infiltration, 
older age and female gender (reviewed by Duval 
and Hamelin 2002). Recently, the MSI-L 
phenotype has been reported to occur in 7-14% of 
sporadic CRCs (Goel et al. 2003, Tang et al. 2004) 
of cases. 
CRC has also served as a model for genetic 
changes in tumour progression. Non-MSI-H 
cancers have been observed to lose on average 
25% of randomly chosen alleles, occurring in 
stepwise alterations from normal epithelium via 
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adenoma to subsequent carcinoma (Fearon and 
Vogelstein 1990, Kinzler and Vogelstein 1996). 
This pathway or “Vogelgram”, as presented by 
Goel et al. (2003), of tumour suppressor gene 
inactivation is based on the sequential 
accumulation of particular mutations and LOH 
(e.g. APC, K-RAS, TP53 and DCC genes) during 
the adenoma-carcinoma transition (reviewed by 
Fearon and Vogelstein 1990 and Kinzler and 
Vogelstein 1996).  
Gastric cancer (GCA) is globally the second 
most common cause of cancer death. GCA is a 
heterogeneous disease where a variety of subtypes 
with different prognoses can be seen. Different 
classifications for GCA are used (Laurén 1965, 
Oota and Sobin 1990, Ming 1998). Association of 
Helicobacter pylori infection with 80% of gastric 
cancers has been described. The eradication and 
decreased incidence of H pylori has lowered GCA 
incidence significantly in Western countries 
(reviewed by Sipponen 2002). Correa (1992) and 
Sipponen (2002) have described sequential 
histological changes (i.e. chromic atrophic 
gastritis, intestinal metaplasia and dysplasia) in 
normal gastric epithelium leading to carcinoma. 
However, the molecular mechanisms beyond these 
changes are poorly understood, since no single 
genomic abnormality is known to be specific for 
sporadic GCA (reviewed by Zheng et al. 2004). 
Based on histology, GCA can be divided into two 
major morphologic categories, i.e. intestinal 
(IGCA) and diffuse (DGCA) types, which 
comprise approximately 90% of the 
adenocarcinomas (Laurén 1965). The remainng 
10% represent unclassified (mixed) type (Laurén 
1965, Sipponen 2002). IGCA shows differentiated 
structures, e.g. gland formation, and its 
pathogenesis has been linked to pre-existing gastric 
atrophy, intestinal metaplasia and dysplasia 
(Correa 1992). DGCA has no known precursor 
lesions, and the cancer cells grow as scattered 
single mucous cells in gastric mucosa (Correa 
1992, Sipponen 2002). 
The MSI-H phenotype is reported to occur in 
approximately 20-33% of gastric cancers 
(Fleischer et al. 1999, Choi et al. 2000), 
representing the highest level among human 
sporadic cancers. IGCA tumours show higher 
prevalence (15-23%) of MSI-H cancers than 
DGCA tumours (2.5-7%) (Buonsanti et al. 1997, 
Choi et al. 2000, Habano et al. 2000, Hayden et al. 
2000, Kim et al. 2003). Already at early stages 
GCA is thought to harbour LOH (Tamura et al. 
1996, Nishizuka et al. 1998). However, unlike in 
colorectal cancer, no clear sequential accumulation 
of genetic alterations has been found upon 
progression of GCA (Zheng et al. 2004).  
 
 
 
6. TUMOURS AS MODELS FOR MICROSATELLITE MUTATIONS 
 
 
As described above, microsatellite mutation rates 
have been inferred from family data, pedigree 
analysis or from population diversity data. 
Mutations most probably occur also in somatic 
tissues, but seldom become visible because of the 
polyclonality of cells (Mann et al. 2003). Tumours, 
however, represent genetically unstable lineages of 
cell clones which have undergone clonal selection 
and considerable numbers of cell division. Thus 
tumour genomes manifest numerous mutations 
(Tomlinson et al. 2002c). Few reports on the use of 
tumours for modelling microsatellite mutations 
have been published (Hoff-Olsen et al. 1998, Di 
Rienzo et al. 1998, Sturzeneker et al. 1998, 2000, 
Bacon et al. 2000). It has been suggested that the 
somatic mutation patterns and mechanisms 
observed in cancer do not differ significantly from 
those in normal germ-line cells (Di Rienzo et al. 
1998, Sturzeneker et al. 1998, 2000). The amount 
of MSI seen at a particular locus in tumours has 
therefore been observed to be associated with its 
diversity at the population level (Di Rienzo et al. 
1998, Sturzeneker et al. 2000).  
Generally the somatic mutation rates at most 
loci are too low, even in tumours, to be efficiently 
detected by PCR (Shibata et al. 1996). However, 
the mutation rates in MSI-H tumours or MSI-H 
cell lines have been estimated to be 100 to 1000 
fold higher than in MMR-proficient cells 
(Bhattacharyya et al. 1994, Eshleman et al. 1996, 
Umar et al. 2004b). Unrepaired slippage during 
DNA replication is the likely mechanism for 
microsatellite mutations in MMR-deficient cells, 
thus linking mutation with cell division (Blake et 
al. 2001). Accordingly, a mutation frequency of 5-
10     x10 –3 has been observed for dinucleotide 
microsatellites in MMR-deficient cell lines 
(Shibata et al. 1996). Poly(A) deletions (like at the 
26 adenine residues of BAT-26 locus) occur 
stepwise in MMR-deficient cancers. Larger 
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poly(A) deletions in tumours suggest for multiple 
contraction events, and thus counting the number 
of deletions gives an estimate of the number of cell 
divisions after the loss of MMR proficiency (Blake 
et al. 2001, Kim et al. 2002). Differences between 
the germ-line genotype and the final founder cell 
of the tumour reflect the number of mitotic 
divisions that occur during tumorigenesis and thus 
can be utilised to reconstruct the history of the 
tumour (Tsao et al. 2000). Comparing the 
mutational events at different loci in a MSI-H 
tumour may give an estimate of their mutational 
frequencies.  
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AIMS OF THE PRESENT STUDY 
 
The aims of the present study were as follows: 
 
1. To evaluate neoplastic tissues as a source of genetic information in forensic settings. 
 
2. To investigate the applicability of tetranucleotide markers, primarily used in forensic 
identity testing, to assess the genetic integrity of gastrointestinal tumours with a special 
emphasis on gastric cancer. 
 
3. To estimate the variability of the alleles generated by MSI tumours and to correlate their 
distribution in alleles found at corresponding loci in the Finnish population. 
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MATERIALS AND METHODS 
 
 
 
1. TISSUE SPECIMENS AND DNA EXTRACTION (I-IV) 
 
 
Surgically resected tissue specimens from primary 
gastrointestinal (GI) cancers and from their 
completely separated cancer-free adjacent areas 
were collected and fresh-frozen during the period 
1995 to 2003 at the Department of Pathology of 
Jorvi Hospital, Espoo, Finland. Histopathological 
diagnosis was obtained from routinely stained tissue 
sections. Care was taken during preparation on the 
histology of the tumour samples to achieve 
adequate tumour cell content. The tissues were 
disrupted by proteinase K digestion and the DNA 
was purified in Qiaquick columns (Qiagen, Hilden, 
Germany). 
A total of 66 GI cancer specimens were used in 
the studies, of which 27 were colorectal and 39 
were gastric cancers. In addition, in study II two 
gastrointestinal stromal tumours (GIST) were 
included. Some of the samples were used in 
multiple studies, and study III included GCA 
samples not included elsewhere, thus the total 
number of samples is greater than in any of the 
individual studies. The number and origin of GI 
tumours analysed in studies I-IV are indicated in 
Table 4.  
In study III the 37 gastric cancers investigated 
were stratified into intestinal (25) and diffuse (12) 
type by routine microscopy according to Laurén 
(1965), and the tumour cell content (50%-100%) 
was estimated from the tissue samples. The 103 
samples representing the Finnish population (IV) 
consisted of adjacent tissues of surgically removed 
tumours and lymphocyte samples of non-related 
healthy individuals. The DNA from lymphocytes 
was purified with proteinase K digestion followed 
by phenol/chlorophorm extraction (Sambrook et al. 
1989).  
 
 
 
Table 4. Number of gastric (GCA) and colorectal (CRC) tumour samples used in each study (I-IV). 
 
 
Study GCA 
(n) 
CRC 
(n) 
Total 
(n) 
I 18 23 41 
II 22 22 46 
III 37 - 37 
IV 30 27 57 
 
 
 
 
 
 
 
 
 
2. TUMOUR GENOTYPING (I-IV) 
 
 
The tumours and their adjacent healthy tissues 
were genotyped separately with the AmpFlSTR® 
SGM Plus™ and AmpFlSTR® Profiler ™ kits 
(Applied Biosystems, Foster City, CA, USA), 
which consist of primers for 15 autosomal 
tetranucleotide markers and primers for the 
amelogenin gene for gender typing. The 
chromosomal locations of the loci are shown in 
Table 5. The PCR procedures, fragment separation 
and genotyping analysis were carried out by ABI 
Prism CE 310 and 3100 capillary electrophoresis 
(Applied Biosystems) according to the 
manufacturer’s instructions. The resulting DNA 
profile from each tumour and its adjacent normal 
tissue were compared and the tumour samples 
were categorised into phenotypes according to the 
autosomal allelic alterations.  
 
2.1. Microsatellite unstable phenotypes (I-IV) 
The MSI phenotype showed emergence of novel 
alleles and was divided into two groups according 
to the NCI recommendations (Boland et al. 1998). 
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The samples with extra alleles at > 5/15 loci were 
designated as MSI-H whereas samples with extra 
alleles at < 5/15 loci were designated as MSI-L. 
The accuracy of the forensic markers to detect the 
MSI-H phenotype was confirmed with 
amplification of BAT-26 (Hoang et al. 1997, 
Halling et al. 1999).  
 
2.2. Phenotypes with LOH (I-III)  
A tumour sample was considered to have LOH at a 
locus when the ratio of fluorescence intensities 
(LOH ratio) between the tumour sample (Yt/Xt) 
and the respective normal tissue (Yn/Xn) fell 
below 0.5 (D’Adda et al. 1999). A locus was 
considered as informative for LOH when the 
normal genotype was heterozygous and the locus 
did not show MSI in the tumour tissue. For studies 
I and II, samples with LOH at <33% of the 
informative loci were designated as low-level LOH 
(LOH-L) and samples with LOH at >33% of the 
loci were designated as high-level LOH (LOH-H). 
In study III the value of >25% for LOH-H was 
used according to Choi et al. (2000). 
 
2.3. Microsatellite stable phenotypes (I-IV)  
In genetically stable tumours no alterations were 
detectable. In the studies I and II both MSI and 
LOH negative tumours were categorised as 
microsatellite stable (MSS). In study III the LOH 
negative phenotype was designated as LOH-non 
detectable (LOH-N) according to Choi et al. (2000) 
and the genetically stable phenotype as MSS/LOH-
N. 
 
 
 
 
 
Table 5. Loci used in studies I-IV. The chromosomal locations are given according to the EMBL 
database (www.ensembl.org), Human Genome Database (www.gdb.com) or Y-STR database 
(www.yhrd.org). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Multiplex used Locus 
 
Chromosomal 
location 
TPOX  Profiler Plus a 2p25.3 
D2S1338 SGM b  2q35 
D3S1358 SGM Profiler Plus 3p21.31 
FGA SGM Profiler Plus 4q31.3 
CSF1PO  Profiler Plus 5q33.1 
D5S818  Profiler Plus 5q23.2 
D7S820  Profiler Plus 7q21.11 
D8S1179 SGM  8q24.13 
TH01 SGM Profiler Plus 11p15.5 
VWA SGM Profiler Plus 12p13.31 
D13S317  Profiler Plus 13q31.1 
D16S539 SGM  16q24.1 
D18S51 SGM  18q21.33 
D19S433 SGM  19q12 
D21S11 SGM  21q21.1 
AMEL SGM Profiler Plus Yp11.2, Xp22.2 
DXS7423 X-tetraplex d  Xq28 
DXS8377 X-tetraplex  Xq28 
DXS101 X-tetraplex  Xq22.1 
ARA X-tetraplex  Xq12.2 
DYS393 9-plex d  Yp11.2 
DYS389 9-plex  Yq11.21 
DYS391 9-plex 10-plex d Yq11.21 
DYS437  10-plex Yq11.21 
DYS438  10-plex Yq11.21 
DYS439  10-plex Yq11.21 
DYS390 9-plex  Yq11.221 
GATA-H4  10-plex Yq11.221 
DYS385 9-plex  Yq11.222 
DYS392 9-plex 10-plex Yq11.222 
GATA-A7.1  10-plex Yq11.222 
DYS19 9-plex 10-plex Yp11.2 
DYS435  10-plex Yq11 
DYS436  10-plex Yq11 
BAT-26   2p21 
aAmpFlSTR® Profiler Plus™ 
b AmpFlSTR® SGM™ 
d multiplexes developed in our laboratory 
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3. AMELOGENIN TYPING (I,II) 
 
AmpFlSTR® SGM Plus™ and AmpFlSTR® 
Profiler ™ multiplexes include the determination 
of gender by amplification of the amelogenin locus 
in the X and Y chromosomes. Although given the 
same gene name, the X- and Y-chromosomal 
amelogenin genes are not identical. The primer set 
which is commonly used in gender determination 
flank a region where the Y-chromosomal gene 
harbours a 6-bp insertion as compared to the X-
chromosomal homologue (Sullivan et al. 1993). 
The different sizes of the amplification products, 
103 bp and 109 bp for X and Y, respectively, thus 
allow typing of the gender. Alternate PCR primers 
(Steinlechner et al. 2002) for amelogenin 
amplification were synthesised with binding sites 
flanking the amelogenin amplicon of the 
genotyping kits.  
 
4. MULTIPLEX Y-CHROMOSOMAL 
ANALYSIS (II) 
 
Y-STR amplification was perfomed in two 
multiplexed PCR reactions (9-plex and 10-plex, 
Table 5) for 16 different Y-chromosomal STRs 
(Kayser et al. 1997, Ruitberg and Butler 2000, 
Hedman et al. 2004) and analysed by ABI Prism 
CE 310 capillary electrophoresis. The number of 
repeat units was calculated by the apparent 
fragment size and by comparison with individuals 
with known haplotype (Hedman et al. 2004). To 
exclude the possibility that the Y-chromosomal 
haplotype came from a minority of cellular clones 
while the majority lacked the entire Y 
chromosome, a stable X-chromosomal marker 
DXS7423 (Zarrabeitia et al. 2002a) was included 
in the 9-plex reaction. The sets of nine and ten Y-
STRs have four markers in common, which 
enabled comparison of both sets with respect to the 
DXS7423 signal. The peak intensity ratios of the 
X- and Y-chromosomal signals were analysed in 
both tumours and control tissue. 
 
5. MULTIPLEX X-CHROMOSOMAL 
ANALYSIS (IV) 
 
The PCR primers for DXS7423, DXS8377, 
DXS101 and ARA were synthesised as described 
by Zarrabeitia et al. (2002b) with appropriate 
fluorescent labels (TAGC, Copenhagen, 
Denmark). The amplifications were performed in a 
tetraplex reaction with a touch-down protocol 
described by Kayser et al. (2004) and analysed by 
capillary electrophoresis. The number of repeat 
units was calculated by the apparent fragment size 
according to Zarrabeitia et al. (2002b) and verified 
by sequencing of appropriate samples.  
 
6. STATISTICS (I-IV) 
 
SPSS software was used in the statistical analyses. 
Pearson correlation test, t-test, Mann-Whitney U 
test, Fisher’s exact probability test and Chi-square 
test were used where appropriate. Polymorphic 
information content (PIC) and heterozygosity 
index (HET) for the X-chromosomal population 
data was calculated using the PowerStats V12 
software. 
 
7. ETHICS (I-IV) 
 
The study protocol was evaluated and approved by 
the institutional ethics committee of the University 
Hospital Helsinki.  
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RESULTS 
 
 
 
1. MSI AND LOH PHENOTYPES (I-IV) 
 
 
In studies I-IV a total of 66 gastrointestinal 
tumours were analysed for MSI, of which 11 
(17%), 15 (22%) and 40 (61%) were categorised as 
MSI-H, MSI-L and MSS phenotypes respectively. 
Additional phenotyping by the BAT-26 assay 
showed 100% consistency with the observed MSI-
H phenotypes of the autosomal tetranucleotide 
microsatellite markers. The apparently normal 
control tissues produced normal-looking genotypes 
with near-to-equal peak intensities for 
heterozygote signals. Table 6 indicates the 
proportions of MSI phenotypes found in gastric 
and colorectal cancers (I,II,IV) and in the intestinal 
and diffuse type of gastric cancers (III). The two 
GIST tumours in study II were of the MSS type 
(omitted from the summarised results). However, 
Table 6 indicates separately the distributions of the 
LOH and MSI phenotypes. These phenotypes were 
partly overlapping, but 41% of the samples did not 
manifest either MSI or LOH categories of 
alterations (i.e. the MSS/LOH-N phenotype). No 
statistically significant difference in MSI 
frequency between GCA and CRC was found. In 
gastric cancer IGCA harboured significantly more 
MSI (p=0.012, Fisher’s exact test) than did DGCA. 
However, the difference in distribution of MSI-L 
(p=0.064) or MSI-H (p=0.389) alone between 
IGCA and DGCA was not significant.  
Figure 7 indicates the instability of individual 
autosomal markers and BAT-26 in the MSI 
tumours. The marker instability rates correlated 
with the instability in the two MSI phenotypes, 
ranging from 0 to 20% and from 9 to 91% in MSI-
L and MSI-H, respectively. No marker was stable 
in all MSI-H tumours. Only three markers (TPOX, 
D3S1358 and TH01) were unstable in less than 
50% of the MSI-H tumours. TH01 was found to be 
an exceptionally stable marker, which also had the 
smallest variation at the population level (data not 
shown). In MSI-L tumours, FGA and D19S433 
were the most unstable, showing instability in 20% 
of the tumours. The tumour samples were also 
stratified according to their LOH events (I-III, H. 
Vauhkonen, unpublished results). All of the 15 
autosomal loci showed at least one incidence of 
LOH in the tumour samples. The prevalence of 
LOH was higher in colorectal cancers (57%) than 
in the gastric cancers (33%) (Table 6, H. 
Vauhkonen, unpublished results), but the 
difference was not statistically significant (p=0.08, 
Fisher’s exact test). The proportions of informative 
loci for LOH ranged from 7% to 60% in individual 
tumours (data not shown). The relative frequency 
of LOH at the individual loci in the 23 LOH-
positive cancers is indicated in Figure 8. In study 
III, where IGCA and DGCA were investigated, a 
significant (p<0.001) association of LOH with the 
IGCA type was found compared with DGCA, 
where LOH was found only at locus CSF1PO in 
one sample. The amounts of LOH in the non-MSI-
H IGCA samples are also shown in Figure 8 on 
page 28. 
 
 
 
 
Table 6. Proportions of the MSI and LOH phenotypes in colorectal (CRC) and gastric (GCA) 
cancer, and in intestinal (IGCA) and diffuse (DGCA) type gastric cancer. A cut-off of 25% was 
applied to delineate LOH-H and LOH-L 
 
 
 
 CRC 
n=27 
GCA 
n=39 
IGCA 
n=27 
DGCA 
n=12 
  CRC 
n=27 
GCA 
n=39 
IGCA 
n=27 
DGCA 
n=12 
MSI-H 15% 18% 24% 8.3%  LOH-H 22% 18% 24% 0% 
MSI-L 22% 23% 40% 8.3%  LOH-L 35% 15% 8% 8.3% 
MSS 63% 59% 36% 83.4%  LOH-N 43% 67% 68% 91.7% 
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Figure 7. Instability rates of the autosomal loci and BAT-26 in the 26 gastrointestinal cancers 
showing MSI-H and MSI-L phenotypes. 
 
 
 
 
 
 
 
2. LOSS OF THE Y-CHROMOSOMAL AMELOGENIN GENE (II) 
 
 
Seven of the 46 male tumour samples in study II 
were found to show a diminished (LOH ratio < 
0.5) Y-chromosomal amelogenin signal. A mean 
ratio of 0.91 (range 0.58-1.42) was calculated for 
the 46 adjacent healthy tissue samples. The 
apparent amelogenin deletion was also observed 
when the samples were assayed with the set of 
alternative primers flanking the originally 
amplified region. Results from amplification of the 
16 Y-chromosomal microsatellite loci suggested 
for preservation of the Y chromosome. Four of the 
tumours with observed loss of the Y-chromosomal 
amelogenin gene were of LOH-H, one MSI-H and 
one MSS (a GIST tumour) type, comprising 9% 
(2/22) of colorectal and 18% (4/22) of gastric 
tumours from males.  
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Figure 8. Frequency of LOH at 15 autosomal loci in the 23 LOH positive gastrointestinal tumours 
and in the 19 non-MSI-H IGCA samples. Only informative loci are shown. 
 
 
 
 
 
 
3. X-CHROMOSOMAL MICROSATELLITE ANALYSIS (IV) 
 
 
In the Finnish population sample consisting of 103 
unrelated individuals the X-chromosomal loci 
DXS7423, DXS8377, DXS101 and ARA were 
found to have 4, 19, 15 and 17 alleles, respectively. 
The allelic frequency distributions of the X-
chromosomal markers in the Finnish population 
sample correlated well (p<0.001) with those 
reported for German, Spanish and Korean 
population samples (Edelmann et al. 2001, 
Zarrabeitia et al. 2002a, 2002b, Shin et al. 2004). 
The values calculated for PIC and HET describing 
the polymorphic characteristics of the loci in 
populations were comparable to those reported 
earlier for other populations. The relative 
instability of the X-chromosomal markers analysed 
in MSI-H, MSI-L and MSS gastrointestinal 
tumours is indicated in Figure 9. All of the X-
chromosomal markers were unstable in MSI-H 
cancers, and in MSI-L and MSS tumours a rather 
similar behaviour of the markers could be seen. 
The marker DXS7423, with the least alleles in the 
Finnish population, was unstable in only a subset 
of MSI-H tumours. DXS8377, with the highest 
number of alleles and highest number of repeats, 
was unstable in 53% of non-MSI-H tumours. 
DXS101 was the most unstable in MSI-H tumours, 
where it most efficiently produced new alleles (20 
new alleles in 8 MSI-H tumours). Table 7 shows 
the allelic distribution of DXS101 in MSI-H 
tumours, which was comparable by 66-100% to 
two Caucasian and one Korean population. 
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Figure 9. Frequency of alterations at the X-chromosomal loci in MSI-H, MSI-L and MSS GI tumours. 
 
 
 
 
 
 
 
Table 7. Allele distribution of DXS101 in eight MSI-H tumours and in the Finnish (IV), German 
(Edelmann et al. 2001), Spanish (Zarrabeitia et al. 2002b) and Korean (Shin et al. 2004) populations. 
 
DXS101 Allele number Allele 
distribution
(%) 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 
MSI-H - - - - 3.4 - 3.4 3.4 3.4 13.8 17.2 17.2 17.2 10.3 3.4 3.4 3.4 - - 
Finland - 4.1 0.7 - 9.6 2.7 2.7 3.4 1.4 4.1 30.8 19.2 8.9 5.5 4.1 2.1 0.7 - - 
Germany  0.2 4.4 0.5 0.2 8.4 4.7 1.2 3.2 2.2 6.6 21.3 15.6 11.4 7.9 7.0 2.7 2.4 - 0.1 
Spain - 5.5 - 0.5 8.5 7.5 2.5 1.5 2.5 4.5 15.6 22.1 17.1 3.0 4.0 2.5 2.5 - - 
Korea - - - - - - - 1.1 3.8 10.9 27.8 21.3 18.0 11.3 4.0 0.7 1.1 - - 
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DISCUSSION 
 
 
 
1. USE OF TUMOUR DNA IN FORENSIC SETTINGS (I,II) 
 
 
In some cases, the absence of a sample source from 
a deceased or missing person may necessitate the 
use of tumour tissue in DNA-based paternity or 
identification analysis. One aim of the present 
work was to evaluate the usefulness of 
gastrointestinal tumour samples in forensic 
analyses.  
Only 27 (41%) of the 66 gastrointestinal 
cancers analysed in studies I-IV showed no 
alterations at their autosomal microsatellite loci. 
The rest (59%) showed at least one alteration, 
either MSI, LOH or both. In MSI cases multiple 
alleles were present, most commonly as a three-
allele pattern at a locus. LOH at a certain locus 
was most often seen as an imbalance of the alleles. 
A total loss of the heterozygote signal was seldom 
seen, most probably because of background 
signals given by normal tissue or due to the 
presence of different cellular clones. It was also 
found that male samples with high-level 
autosomal LOH frequently showed LOH at the Y-
chromosomal amelogenin allele resulting in a 
female-like genotype (II). Consequently, a failure 
in gender determination may lead to false identity, 
because samples are often grouped dichotomously 
by sex. False results in gender typing have been 
reported to occur also at the population level, e.g. 
0.2% of males in Sri Lankan populations have 
been observed to lack the Y-chromosomal 
amelogenin peak when analysed with the 
commonly used primers (Santos et al. 1998, 
Roffey et al. 2000, Steinlechner et al. 2002, 
Tharangaj et al. 2002, Chang et al. 2003, Michael 
and Brauner 2004). 
Recently, analysis of the applicability of tumour 
DNA in forensic settings has been conducted using 
oral (Pai et al. 2002), pancreatic (Schwark et al. 
2004), head and neck, renal cell and colon 
carcinomas, and melanomas (Poetch et al. 2004). 
The results from these studies indicate that use of 
neoplastic tissue in DNA profiling may lead to 
erroneous interpretation of identity. Degraded or 
scarce material, like paraffin-embedded specimens, 
may also yield artefactual MSI and LOH findings 
(Sieben et al. 2000, Tomlinson et al. 2002b). In 
general, when neoplastic samples are used as a 
source of DNA one must be aware that an apparent 
homozygote might result from LOH (Rubocki et 
al. 2000) and an apparent heterozygote from MSI 
alteration. A simple solution would be a 
histological analysis of the specimen to obtain a 
marginal cut from normal-looking areas. However, 
histologically normal tissues adjacent to a tumour 
may also harbour DNA alterations (Lindforss et al. 
2003). In less than one half of the cases DNA from 
neoplastic tissues could be considered as suitable 
for forensic casework. An MSI-H sample without 
the corresponding control tissue could easily be 
detected by at least one three-or-more-allele locus, 
but the detection of LOH without control tissue 
may not be straightforward. Especially in paternity 
cases, the observed somatic mutations may lead to 
false exclusions. In conclusion, when 
inconsistencies are noticed, deductions from these 
profiles should be performed with extreme care.  
 
 
2. ASSESSING THE GENETIC INTEGRITY OF TUMOURS BY MARKERS OF 
FORENSIC INTEREST (I-IV) 
 
 
The NCI panel of microsatellite markers (Boland 
et al. 1998) was established to achieve a more 
uniform approach to evaluate the MSI-H 
phenotype in colorectal cancer. The five markers 
chosen for the panel were mono- and 
dinucleotides, while tetranucleotide markers were 
considered to be less mutable (Dietmaier et al. 
1997, Boland et al. 1998). The polymorphic 
autosomal tetranucleotide markers used in studies 
I-IV are routinely applied in human identification. 
These markers were frequently unstable in the 
tumour specimens, and collectively they revealed 
the same MSI-H cancers than BAT-26. The 
incidence of the MSI-H phenotype was similar 
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between gastric (18%) and colorectal (15%) 
cancers (Table 6), which is in line with previous 
reports (Boland et al. 1998, Halling et al. 1999, 
Choi et al. 2000, Halford et al. 2003, Lawes et al. 
2003) showing MSI-H in 12-15% and 9-17% of 
GCA and CRC, respectively. The distribution of 
the MSI-L and MSS phenotype in gastric and 
colorectal tumours was also similar (Table 6). The 
results indicate that the autosomal tetranucleotide 
markers used in studies I-IV are valid in MSI 
detection and that MSI phenotypes occur similarly 
in GCA and CRC.  
The chromosomal instability of tumours can be 
assessed by e.g. detecting abnormal DNA content 
by flow cytometry, detecting aneuploidy or 
chromosomal rearrangements by cytogenetic 
studies or detecting chromosomal deletions by 
LOH studies (reviewed in Lengauer et al. 1998 and 
Jallepalli and Lengauer 2001). However, the 
mechanism generating apparent LOH is not fully 
understood, as point mutations in the primer 
binding sites also result as apparent LOH. Whole-
genome LOH analysis, i.e. allelotyping, is used for 
the detection of chromosomal losses that are 
common and develop sequentially in the tumour-
type of interest. The best known example of a 
carcinogenetic pathway revealed by allelotyping 
analysis is colorectal cancer (Vogelstein et al. 
1989). Most of the studies on LOH have focused 
on certain chromosomal areas with known or 
suspected tumour suppressor genes. In studies I-III 
the LOH events were found to be unevenly 
distributed among the markers (Figure 8). A high 
frequency (>40%) of LOH was noticed at the 
FGA, CSF1PO and D18S51 loci. The latter 
marker, located in 18q, was mostly deleted in 
colorectal tumours (8/13, 62%, data not shown), in 
accordance with previous studies (Fearon et al. 
1990, Goel et al. 2003). The markers CSF1PO, 
D5S818, D18S51 and D21S11 are located in 
chromosomal arms containing the tumour 
suppressor genes APC, DCC and TFF1, which are 
known to be deleted during gastric carcinogenesis 
(McKie et al. 1993, Fang et al. 1998, Carvalho et 
al. 2002). These markers showed LOH in 15%, 
20%, 20% and 28% of the non-MSI-H IGCA 
tumours, respectively, which is in line with 
previous reports (Tamura et al. 1996, Choi et al. 
1998, Nishizuka et al. 1998). We conclude that 
autosomal markers used in DNA profiling of 
individuals are sensitive also in detecting LOH 
events and are comparable to the markers more 
commonly used in tumour studies. Assessing MSI 
and LOH in the two types of gastric cancer 
indicated that they represent for the most part 
different genetic pathways. A genetically stable 
phenotype is the major entity in DGCA, whereas 
severe genetic lesions (MSI-H and LOH) are 
associated with IGCA. 
The males of study II with frequent LOH also 
showed LOH at the amelogenin region. The 
possibility of allele drop-out as a result of point 
mutations, as reported by Boutrand et al. (2001), 
was excluded by using alternative primers. 
Previous studies report Y-chromosomal deletions, 
either entire or partial, in male gastric tumours 
(Castedo et al. 1992, Van Dekken et al. 2001). 
However, deletion of the amelogenin gene region 
has not been previously reported. The X- and Y-
chromosomal amelogenin genes have been shown 
to be active in the ameloblasts of developing tooth 
buds, where the amelogenin proteins have been 
found as components of the extracellular matrix 
(Salido et al. 1992). Recently the amelogenins 
have also been suggested to have a role in cell 
adhesion and signalling (Veis et al. 2000, Hoang et 
al. 2002). So far, there is little evidence for a 
cancer-related role for the amelogenin proteins. 
Accordingly, to our knowledge, no reports on 
cancer predisposition in males lacking the Y-
chromosomal amelogenin gene exist to date. 
 
 
 
 
3. TUMOURS WITH MICROSATELLITE INSTABILITY MODELLING GERM-LINE 
MUTATIONS (I,IV) 
 
 
A relationship between the diversity of alleles at a 
particular locus in a population and the relative 
mutability in MSI-H cancers has been previously 
observed. Sturzeneker et al. (2000) found the level 
of instability of individual markers in colorectal 
MSI-H tumours to correlate with variables linked 
to germ-line mutation frequency, i.e. the 
population average heterozygosity and variance of 
repeat number of the loci. Di Rienzo et al. (1998) 
estimated the distributions of the size of gains and 
losses at various loci in 219 genetically 
uncharacterised colorectal tumours and related 
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them to allele distributions in populations. They 
found a positive correlation between the locus 
mutability and allelic distribution in different 
populations with known demographic histories. 
The intriguing possibility to use tumours as a 
model to test allelic mutations in relation to a 
population has not been studied previously. 
In study I, we found a positive correlation 
between the germ-line mutation frequency and the 
level of MSI at a given locus in tumours. The data 
for MSI frequencies (I-IV) and germ-line mutation 
rates (www.cstl.nist.gov/ div831/strbase) at the 15 
autosomal loci is summarised in Table 9 and 
Figure 10. The observed positive correlation in the 
mutability of loci was more significant between 
MSI-H and the germ-line mutations (r=0.656, 
p=0.008) than between MSI-L and germ-line 
mutations (r=0.547, p=0.035) or MSI-H and MSI-
L (r=0.480, p=0.070) (Figure 10). This finding 
suggests that the microsatellite instability of 
gastrointestinal tumours reflects the germ-line 
mutation susceptibility, significantly in MSI-H and 
approaching significance in MSI-L. 
 
 
 
Table 9. Frequency (%) of MSI at different loci in MSI-H and MSI-L tumours with respect to 
the observed mutation rates in population.  
 
 
Locus 
 
 
MSI-Ha
n=11 
 
MSI-Lb
n=15 
 
Populationc
TPOX 36% 0 0.01% 
D2S1338 82% 0 0.09% 
D3S1358 45% 7% 0.13% 
FGA 82% 20% 0.30% 
CSF1PO 82% 0 0.16% 
D5S818 55% 7% 0.12% 
D7S820 73% 7% 0.10% 
D8S1179 64% 13% 0.13% 
TH01 9% 0 0.01% 
vWA 73% 7% 0.16% 
D13S317 82% 20% 0.15% 
D16S539 91% 7% 0.11% 
D18S51 91% 7% 0.25% 
D19S433 91% 20% 0.11% 
D21S11 91% 13% 0.21% 
a Frequency of instability in MSI-H tumours. 
b Frequency of instability in MSI-L tumours 
c Data from www.cstl.nist.gov/div831/strbase.
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Figure 10. A graphic presentation of MSI-H and MSI-L mutation frequencies as compared to 
that of the germ-line. The numerical data is presented in Table 9. 
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 Assuming that the mutational mechanisms of 
tumours and the germ-line are similar, tumours 
may be considered as microscopic populations 
with the microsatellites evolving under the same 
constraints than in a human population, but over a 
more rapid time scale (Di Rienzo et al. 1998, 
Sturzeneker et al. 1998, 2000). The different cell 
clones present in an MSI-H tumour originate from 
the founder cell, or the ancestral genotype, which 
has lost its capability to repair replication errors 
(Shibata et al. 1994, Kim et al. 2002). The final 
population of cells that form the tumour can be 
considered as descendants of the same “pedigree”. 
Because a MSI-H tumour may show multiple 
alleles at a single locus (Figure 11), different allele 
combinations represent different lineages of 
tumour cells. 
In study IV the primary question was if 
gastrointestinal tumours representing different 
levels of MSI can produce the set of alleles found 
in a population. It was found that the MSI-H 
tumours most efficiently produced new alleles, all 
of which fell well within the allelic distribution 
found in the Finnish population. The instability of 
a locus was found to correlate with its allelic 
diversity in population. Locus DXS7423, with only 
four alleles in the Finnish population, was the least 
unstable in tumours, while locus DXS8377, with 
nineteen alleles, was unstable in non-MSI-H 
tumours. Locus DXS101 produced the greatest 
number of alleles in the MSI-H tumours. These 
alleles correlated well with the allelic distribution 
observed in the Finnish, German, Spanish and 
Korean population samples (r=0.822-0.955, 
p<0.001) (Edelmann et al. 2001, Zarrabeitia et al. 
2002a, 2002b, Shin et al. 2004). The results 
suggest that a series of MSI-H tumours can be used 
in estimation of the allelic distribution of a 
candidate marker in a population. However, since 
gastrointestinal tumours, germ-line cells and 
populations are subject to different selection, 
population effects, and tissue-specific effects, more 
knowledge is needed before straightforward 
interpretation of the results can be performed. 
Furthermore, marker-specific factors which affect 
the number of alleles and thus variance, such as 
size boundaries and the existence of variant alleles, 
all complicate direct comparison of microsatellite 
mutation frequencies between tumour and germ-
line cells. It would be interesting to further 
evaluate this “tumour model” with data obtained 
from autosomal and Y-chromosomal markers. 
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CELL DIVISIONS
 
 
 
 
Figure 11. Formation of an allelic population in a MSI-H tumour as exemplified with DXS101. 
The electropherogram on the left indicates the genotype (alleles 24 and 25) in normal (N) and 
in tumour (T) tissue (alleles 23,24,25,26 and 27). The circles on the right describe the 
accumulation of single-step mutations in different cell clones. The presence of the normal 
genotype in the tumour tissue may be due to back-and-forth stepwise alteration or retaining of 
an unaltered cell clone, or due to contamination with normal tissue. 
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CONCLUSIONS 
 
 
 
In forensic settings, if tumour tissues are to be used 
as a source for DNA profiling, careful 
interpretation of data and use of stable surrogate 
markers is warranted. The widely used 
tetranucleotide microsatellites as well as the 
gender-specific amelogenin genes are prone to 
MSI and LOH in the gastric and colorectal cancer 
studied here (I,II). In 59% of the cases, alterations 
were found in the DNA from gastrointestinal 
tumour tissues, thus such samples were concluded 
to be unsuitable for forensic studies, especially 
paternity analysis, without strict guidelines. 
Previous studies on MSI and LOH in gastric 
cancer were mainly conducted with mono- and 
dinucleotide markers. Our studies show that 
polymorphic tetranucleotide markers also readily 
detect aberrations in the genetic integrity of 
gastrointestinal cancers. In addition, different 
alteration frequencies were found between IGCA 
and DGCA, where the former harboured a majority 
of the MSI-H, MSI-L and LOH phenotypes, while 
the latter was mainly manifested the stable 
(MSS/LOH-N) phenotype (III). The tumours with 
high LOH frequency were also found to present the 
MSI-L phenotype (III). Another novel finding was 
the loss of the Y-chromosomal amelogenin gene in 
male samples with frequent LOH (II). 
Comparison of allelic distributions between 
gastrointestinal tumours and a Finnish population 
sample consisting of unrelated individuals suggest 
that similar mechanisms of mutation in both 
tumours and germ-line (IV). Complexity of allelic 
structure and number of repeats may contribute to 
the mutational spectrum of a particular locus in the 
evolution of microsatellites upon tumour 
development and as well as in the parental 
transmission of alleles. However, since tumour and 
germ-line cells are subject to different cell-specific 
effects, and tumour cell and human populations are 
subject to different population effects, further 
investigations are needed for straightforward 
integration of the data. 
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